Status:
COMPLETED
Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Preeclampsia
Lead Sponsor:
Mpilo Central Hospital
Conditions:
Severe Preeclampsia
Eligibility:
FEMALE
14+ years
Brief Summary
This proposal describes a single centre retrospective cross-sectional study which will address the need to further develop and test statistical risk prediction models for adverse maternal and neonatal...
Detailed Description
Hypertensive disorders in pregnancy are a leading cause of maternal and perinatal morbidity and mortality, especially in low-resource settings. Identifying mothers and babies at greatest risk of compl...
Eligibility Criteria
Inclusion
- Participants will be included in the study if they have a diagnosis of severe preeclampsia.
- Severe preeclampsia will be defined as high blood pressure (systolic blood pressure (SBP) ≥160, diastolic blood pressure(DBP) ≥110mmHg) and or either severe headaches, epigastric pains and deranged biochemical/haematological blood indices.
- Both singleton and twin/higher order pregnancies will be included.
Exclusion
- Women with mild or moderate preeclampsia or less than 20 weeks' of gestation and those with epilepsy will be excluded from the study.
Key Trial Info
Start Date :
November 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
549 Patients enrolled
Trial Details
Trial ID
NCT04058405
Start Date
November 12 2018
End Date
August 31 2021
Last Update
September 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mpilo Central Hospital
Bulawayo, Matabeleland, Zimbabwe, +263